Alliances & New Ventures

Strategic partnerships and translational research collaborations leverage Scripps Research discoveries, capabilities and technological platforms to accelerate development of innovative therapeutic strategies, enable downstream commercial development and bring forth new medicines for patients.

Additionally, the Office of Technology Development facilitates investment in the maturation of Scripps Research assets and marshals resources to build patient-focused biotechnology firms dedicated to therapeutic development for unmet medical needs. Start-up initiatives leverage internal capabilities for drug development with the goal of advancing assets further into development and creating new medicines that can improve and save lives.